1-4 of 4
E. Domingo-Domenech
Close
Sort by
Journal Articles

CD38 Expression in Chronic Lymphocytic Leukemia (CLL) Patients Is Associated with Family History of Hematological Neoplasms.

E. Domingo-Domenech, A. Domingo-Claros, E. Gonzalez-Barca, Y. Benavente, T. Alvaro, C. Bellas, R. Font, A. Fernandez de Sevilla, S. de Sanjose
Journal: Blood
Blood (2005) 106 (11): 5002.
https://doi.org/10.1182/blood.V106.11.5002.5002
Published: 2005
Journal Articles

Relationship between Seroresponse to Epstein-Barr Virus and Survival in Patients with Lymphoid Malignancies.

E. Domingo-Domenech, J. Middeldorp, E. Gonzalez-Barca, Y. Benavente, V. Romagosa, R. Font, A. Fernandez de Sevilla, C. J. Meijer, S. de Sanjose
Journal: Blood
Blood (2005) 106 (11): 4688.
https://doi.org/10.1182/blood.V106.11.4688.4688
Published: 2005
Journal Articles

First-Line Treatment with R-Chop/21 for Patients with Disseminated Diffuse Large B-Cell Lymphoma (DLCL). Results of a Prospective Series of 128 Patients.

E. Gonzalez-Barca, PhD, E. Domingo-Domenech, MD, J. M. Ribera, PhD, J. Briones, PhD, A. Salar, PhD, L. Gallur, MD, C. Estany, MD, L. Escoda, MD, S. Gardella, MD, J. A. Hernandez, MD, J. Rodriguez, MD, E. Ramila, MD, O. Ramon, MD, M. Garcia-Pinto, MD, I. Español, PhD, P. Vivancos, MD, A. Asensio, MD, M. Encuentra, A. Fernandez de Sevilla, PhD
Journal: Blood
Blood (2004) 104 (11): 4573.
https://doi.org/10.1182/blood.V104.11.4573.4573
Published: 2004
Journal Articles

First-Line Treatment with Rituximab Improves Survival of Patients with Post-Transplant Lymphoproliferative Disease (PTLD).

E. Gonzalez-Barca, PhD, E. Domingo-Domenech, MD, J. Gomez-Codina, MD, F. Capote, MD, E. Flores, MD, J. Briones, PhD, A. Salar, PhD, C. Panizo, MD, C. Montalban, PhD, J. M. Ribera, PhD, D. Caballero, PhD, A. Muñoz, MD, L. Gallur, MD, M.A. Canales, MD, P. Fernandez, MD, M. Encuentra, A. Fernandez de Sevilla, PhD
Journal: Blood
Blood (2004) 104 (11): 1406.
https://doi.org/10.1182/blood.V104.11.1406.1406
Published: 2004